Biodesix
Biodesix is a leading diagnostics solutions company specializing in assay development, validation, and clinical sample testing. We have a proven track record supporting biopharma research across diverse sample types and target molecules, with extensive expertise in characterizing circulating tumor DNA (ctDNA) and other genomic biomarkers. In addition to our industry-leading ddPCR™ and NGS testing platforms, Biodesix offers robust proteomic capabilities, including targeted and untargeted mass spectrometry and immunoassay-based approaches. These complementary genomic and proteomic services enable a multi-omic strategy for biomarker discovery, validation, and clinical trial support, helping our partners accelerate therapeutic development and improve patient outcomes.
